Sequential proleukin(rIL-2) by continuous infusion with cisplatin and cyclophosphamide in patients with unresectable ovarian cancer.
de Dycker
R P
RP
Neumann
R L
RL
Schumacher
T
T
Heckmann
U
U
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D010051:Ovarian Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000009:adverse effects
D007376:Interleukin-2; D011994:Recombinant Proteins